Slaoui Apologizes For Sexual Harassment, Loses Further Industry Roles
Exits Vaxcyte And Centessa
Executive Summary
The former Operation Warp Speed leader has apologized unreservedly for his actions, and loses positions with two biopharma companies.
You may also be interested in...
Moncef Slaoui Fired From GSK Role After Sexual Harassment Inquiry
Pharma firm calls behaviour “wholly unacceptable” after external investigators back up employee allegations.
Centessa Looks To Transform Drug Development With ‘Asset Centric’ Model
In an interview with Scrip, CEO Saurabh Saha elaborates on the first-of-its-kind R&D model.
Beam Therapeutics’ Base-Edited CAR-T Placed On Hold
Beam is the latest allogeneic CAR-T developer to face a regulatory hold-up, but other candidates using its pioneering base-editing technology are now progressing.